PharmStockPharmacy Stock

Casodex
Casodex

8.13
A generic medicine indicated for oncology care. Prevents hormone signals from binding to receptors to limit the progression of cancer cells.
Ingredient
Bicalutamide
Category
Oncology Support
Availability
In Stock
Delivery Time
Airmail (14-21 days) | Trackable (5-9 days)
Shipped in a discreet, unmarked envelope with all required documents enclosed.

Product Sheet

Active Ingredient(s)
Bicalutamide
Reference Brand
Bicalutamide
Product Origin
Generic Alternative
Reference Manufacturer
AstraZeneca
Product Form
Tablet
Regulatory Classification
Prescription Only Medicine
Primary Category
Hormones
Product Category
Antiandrogen
Pharmacological Class
Androgen Receptor Inhibitor
Clinical Indications
Prostate cancer
Manufacturer Description
Formulated to alleviate androgenic stimulation to support therapeutic oncology goals and target tumor progression.
Mechanism of Action
Competitively binds to cytosol androgen receptors in the prostate gland, blocking the growth stimulus of testosterone.
Route of Administration
Oral
Onset Time
1–2 weeks
Duration
24 hours
Contraindications
Pregnancy, Hypersensitivity to bicalutamide
Severe Adverse Events
Severe hepatotoxicity — requires immediate medical attention, Interstitial lung disease — requires immediate medical attention
Common Side Effects
Hot flashes, Breast tenderness, Nausea
Uncommon Side Effects
Gynecomastia, Fatigue, Elevated liver enzymes
Drug Interactions
Warfarin
Pregnancy Safety Warnings
TGA Category X: Highly contraindicated. Causes fetal abnormalities. Breastfeeding: Not applicable.
Age Restrictions
Approved for adult men.
Storage Guidelines
Store below 25°C.
Related Products
Eulexin
Information related to Casodex is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
Categories
where to order Premature Ejaculation AU - Malegra FXT Price AU